Doxycycline for Children With Lyme Disease: Benefits and Risks
Doxycycline is commonly used to treat Lyme disease in adults, but its use in young children remains controversial. Physicians must weigh the benefits of doxycycline against the potential risk of permanent tooth staining associated with tetracycline antibiotics.
Doxycycline in children with Lyme disease may be appropriate in selected cases, particularly when coinfections are suspected or when broader antimicrobial coverage is needed.
For a broader overview, see Lyme disease in children and managing Lyme disease in children.
Why Doxycycline Is Used for Lyme Disease
Doxycycline is effective against Borrelia burgdorferi, the bacterium responsible for Lyme disease. It also treats several tick-borne coinfections, including Anaplasma and Ehrlichia.
This broader coverage is one reason doxycycline may be preferred in more complex presentations.
Risk of Tooth Staining in Young Children
Tetracycline antibiotics have historically been avoided in young children due to the risk of permanent tooth staining.
This risk is highest in children younger than 5–6 years, when permanent teeth are still developing.
“Because calcification of permanent teeth is largely complete by 5–6 years of age, children younger than 4 years are at highest risk,” Wormser explains.
Doxycycline Compared With Older Tetracyclines
Doxycycline binds calcium less avidly than earlier tetracyclines, which may reduce the risk of dental staining.
In small pediatric studies, doxycycline did not result in tooth staining, though these studies were limited in size and duration.
The long-term risk remains uncertain and may depend on cumulative exposure.
American Academy of Pediatrics Guidance
In 2018, the American Academy of Pediatrics updated its guidance, stating that doxycycline may be used for up to 21 days in young children when clinically indicated, including early Lyme disease.
This reflects a shift toward individualized risk–benefit assessment rather than strict age-based avoidance.
Is Doxycycline Recommended for Children With Lyme Disease?
“The recommendation to use doxycycline in young children with early Lyme disease should be based on assessment of the risk-to-benefit ratio,” writes Wormser.
Clinicians should consider:
- Age of the child
- Severity of illness
- Likelihood of coinfection
- Prior antibiotic exposure
In some cases, alternative antibiotics may be preferred.
Alternative Antibiotics for Children
Amoxicillin and cefuroxime are commonly used alternatives for children with Lyme disease when doxycycline is not indicated.
These options are often preferred when coinfections are not suspected.
When coinfections such as Babesia and Bartonella in children are a concern, doxycycline may still be considered.
Single Dose of Doxycycline for a Tick Bite
A single dose of doxycycline is sometimes used after a tick bite to prevent Lyme disease.
“It seems unlikely that one dose would cause dental staining in young children,” writes Wormser.
However, there is limited evidence that a single dose prevents long-term or chronic manifestations of Lyme disease.
Clinical Perspective
In clinical practice, treatment decisions for children with Lyme disease are individualized.
Age, symptom severity, risk of coinfection, and prior antibiotic exposure all influence the decision to use doxycycline.
Careful evaluation is essential to balance effectiveness with safety.
Frequently Asked Questions
Is doxycycline safe for children with Lyme disease?
Short courses may be appropriate in selected cases when benefits outweigh risks.
Can doxycycline stain children’s teeth?
There is a potential risk, especially in younger children, though doxycycline may pose a lower risk than older tetracyclines.
What antibiotics are used for children with Lyme disease?
Common options include amoxicillin, cefuroxime, and in some cases doxycycline.
Related Pediatric Lyme Articles
Single dose doxycycline outcomes
Tick bite prevention in children
Parent experiences with pediatric Lyme
References
- Wormser GP, Strle F, Shapiro ED. Pediatr Infect Dis J. 2019.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
